Floatz logo

162 assets in Mantle Cell Lymphoma

Therapeutic assets addressing Mantle Cell Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Etoposide
Mantle Cell Lymphoma
Ruijin HospitalP4BBB (75)
Cis-Diamminedichloroplatinum Ii
Mantle Cell Lymphoma
National Cancer Institute (NCI)P4BBB (74)
Busulfanum
Mantle Cell Lymphoma
City of Hope Medical CenterP2BBB (72)
Cyclosporin A
Mantle Cell Lymphoma
Fred Hutchinson Cancer CenterP3BBB (72)
Irinotecan
Mantle Cell Lymphoma
University of Michigan Rogel Cancer CenterP2BBB (72)
Vincristine Sulfate
Mantle Cell Lymphoma
M.D. Anderson Cancer CenterP2BBB (72)
Cediranib
Mantle Cell Lymphoma
City of Hope Medical CenterP2BB (71)
Cyclophosphamide
Mantle Cell Lymphoma
Miltenyi Biomedicine GmbHP4BB (71)
Rituximab
Mantle Cell Lymphoma
City of Hope Medical CenterP4BB (71)
Adriamycin
Mantle Cell Lymphoma
National Cancer Institute (NCI)P4BB (70)
Prednisone
Mantle Cell Lymphoma
National Cancer Institute (NCI)P4BB (70)
Selinexor
Mantle Cell Lymphoma
Zhengzhou UniversityP4BB (70)
(+)-Vincristine
Mantle Cell Lymphoma
National Cancer Institute (NCI)P4BB (70)
Alisertib
Mantle Cell Lymphoma
National Cancer Institute (NCI)P2BB (69)
Tacrolimus
Mantle Cell Lymphoma
University of Michigan Rogel Cancer CenterP3BB (69)
Vorinostat
Mantle Cell Lymphoma
University of Michigan Rogel Cancer CenterP2BB (68)
Ibrutinib
Mantle Cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.P4BB (67)
Cytarabine
Mantle Cell Lymphoma
National Cancer Institute (NCI)P4BB (66)
Dexasone
Mantle Cell Lymphoma
National Cancer Institute (NCI)P4BB (66)
Nivestim
Mantle Cell Lymphoma
Fred Hutchinson Cancer CenterP2BB (66)
Rocbrutinib
Mantle Cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.P3BB (66)
Bendamustine
Mantle Cell Lymphoma
Tianjin Medical University Cancer Institute and HospitalP3BB (65)
Fludarabine
Mantle Cell Lymphoma
Miltenyi Biomedicine GmbHP3BB (65)
Nivolumab
Mantle Cell Lymphoma
University of WashingtonP2BB (65)
Pirtobrutinib
Mantle Cell Lymphoma
Fondazione Italiana Linfomi - ETSP3BB (65)
Sonrotoclax
Mantle Cell Lymphoma
Canadian Cancer Trials GroupP3BB (65)
Obinutuzumab
Mantle Cell Lymphoma
National Cancer Institute (NCI)P2BB (64)
Zanubrutinib
Mantle Cell Lymphoma
Canadian Cancer Trials GroupP3BB (64)
Zilovertamab
Mantle Cell Lymphoma
Oncternal Therapeutics, IncP3BB (64)
Orelabrutinib
Mantle Cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.P3B (63)
Prednisolone
Mantle Cell Lymphoma
Beijing InnoCare Pharma Tech Co., Ltd.P3B (63)
Acalabrutinib
Mantle Cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.P3B (62)
Lenalidomide
Mantle Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP3B (62)
Venetoclax
Mantle Cell Lymphoma
The Lymphoma Academic Research OrganisationP3B (62)
Zuberitamab
Mantle Cell Lymphoma
Zhengzhou UniversityP4B (62)
Bortezomib
Mantle Cell Lymphoma
Ruijin HospitalP3B (61)
Camustine
Mantle Cell Lymphoma
Ruijin HospitalP3B (60)
Melphalan
Mantle Cell Lymphoma
Ruijin HospitalP3B (60)
Methotrexate
Mantle Cell Lymphoma
Shandong Provincial HospitalP3B (60)
Polatuzumab Vedotin
Mantle Cell Lymphoma
Czech Lymphoma Study GroupP2B (60)
Thalidomide
Mantle Cell Lymphoma
Zhengzhou UniversityP4B (60)
Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,461-Alanine,462-Alanine,556-Glycine,581-Cysteine,593-Tryptophan), Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 Vh-Ch1 Fragment) Fusion Protein With Peptide (Synthetic 10-Amino Acid Linker) Fusion Protein With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Heavy Chain Vl(.Lambda.)-Ch1-Ch2-Ch3), (222->219''')-Disulfide With Immunoglobulin Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)) And (447->232'')-Disulfide With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Light Chain Vh-Cl(.Kappa.)), (453->228'), (456->231'), (581->351')-Tris(Disulfide) With Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,236-Alanine,237-Alanine,331-Glycine,351-Cysteine,368-Serine,370-Alanine,409-Valine) Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Gamma.1-Chain) Disulfide With Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)
Mantle Cell Lymphoma
National Cancer Institute (NCI)P2B (59)
Oxaliplatin
Mantle Cell Lymphoma
National Cancer Institute (NCI)P2B (58)
Brexucabtagene Autoleucel
Mantle Cell Lymphoma
Vanderbilt-Ingram Cancer CenterP2B (57)
Pembrolizumab
Mantle Cell Lymphoma
Celldex TherapeuticsP1/2B (57)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit
Mantle Cell Lymphoma
M.D. Anderson Cancer CenterP2B (56)
Recombinant Human Hyaluronidase
Mantle Cell Lymphoma
Academic and Community Cancer Research UnitedP3B (56)
Copanlisib
Mantle Cell Lymphoma
City of Hope Medical CenterP2CCC (55)
Autologous Cd4+ And Cd8+ T Cells, Enriched From Peripheral Blood Mononuclear Cells (Pbmcs) Transduced With A Nonreplicative Self-Inactivating (Sin) Lentiviral Vector Encoding A Chimeric Antigen Receptor (Car) Consisting Of The Human Cd19-Specific Scfv, An Lgg4 Hinge Region, Cd28 Transmembrane Domain, Cd137 (4-1Bb) Co-Stimulatory Domain And Cd3 Zeta Signalling Domain, Under The Control Of A Hybrid Elongation Factor 1 Alpha (Ef1.Alpha.) And Human T Cell Leukemia Virus Type 1(Htlv-1) Regulatory Element Promoter And Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element (Wpre). The Vector Genome Also Encodes A Truncated Human Epidermal Growth Factor Receptor (Egfrt) That Is Co-Expressed With The Car And Cleaved From It By The T2A Self-Cleaving Peptide. The Vector Genome Also Contains A Splice Donor, A Fragment Of Gag, A Rev Response Element (Rre), A Mutated Central Polypurine Tract (Cppt), And A Splice Acceptor
Mantle Cell Lymphoma
Sun Yat-sen UniversityP2CCC (53)
cd19car-cd28-cd3zeta-egfrt-expressing tn/mem-enriched t-lymphocytes
Mantle Cell Lymphoma
City of Hope Medical CenterP2CCC (53)
Showing 1 to 50 of 162 assets
PreviousPage 1 of 4Next